# Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)

> **NCT00332033** · PHASE2 · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 32 (—)

## Conditions studied

- Uterine Leiomyoma
- Fibroids

## Interventions

- **DRUG:** Pirfenidone

## Key facts

- **NCT ID:** NCT00332033
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05-25
- **Primary completion:** —
- **Final completion:** 2007-02-16
- **Target enrollment:** 32 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332033, "Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00332033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*